NEW YORK, Dec. 03, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of ERBA Diagnostics, Inc. (“ERBA”) (NYSEMKT:ERB) between April 14, 2014 and November 20, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired ERBA securities between April 14, 2014 and November 20, 2015, your rights may be affected by this action.To get more information go to:
http://zlk.9nl.com/erba-diagnostics
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, Defendants’ statements about ERBA’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in ERBA you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Robinhood Expands Sports Event Contracts With Player Performance Wagers
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 



